Skip to main content
Publication date
2018 Apr 12
Authors
Smith, MR Saad, F Chowdhury, S Oudard, S Hadaschik, BA Graff, JN Olmos, D Mainwaring, PN Lee, JY Uemura, H Lopez-Gitlitz, A Trudel, GC Espina, BM Shu, Y Park, YC Rackoff, WR Yu, MK Small, EJ
Group authors
SPARTAN Investigators
Pubmed ID
29420164
Journal
The New England journal of medicine
Doctype
Article
KI Connection
Låg
Mesh SV
Adenokarcinom Androgenblockerare Dubbelblindmetod Hudutslag Kastrationsresistenta prostatatumörer Manlig Medelålders personer Metastaser Människa Proportional hazard-modeller Prostataspecifikt antigen Sjukdomsfri överlevnad Sjukdomsförlopp Tiohydantoiner Äldre Äldre, 80 och över
Mesh EN
Adenocarcinoma Androgen Antagonists Disease-Free Survival Disease Progression Double-Blind Method Exanthema Neoplasm Metastasis Proportional Hazards Models Prostate-Specific Antigen Prostatic Neoplasms, Castration-Resistant Thiohydantoins
First date
2018-04-30T01:42:10.933Z